Philippe Mochirian

Title: Philippe Mochirian: Innovator in Nucleoside Analogues

Introduction

Philippe Mochirian is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of nucleoside and nucleotide analogues. With a total of 2 patents, his work focuses on creating compounds that have potential applications as anticancer and antiviral agents.

Latest Patents

Mochirian's latest patents include innovative compounds that serve as nucleoside and nucleotide analogues. One of his patents details compounds that can be utilized as anticancer or antiviral agents. These compounds feature tetrahydrofuranyl or tetrahydrothienyl moieties with a quaternary stereogenic all-carbon center at the 3' position, along with a phosphoryl group at either the C5' and/or C3' positions. Another patent describes nucleoside and nucleotide analogues that act as cardioprotective agents. These compounds also include tetrahydrofuranyl or tetrahydrothienyl moieties, but with quaternary stereogenic all-carbon centers at the 2' position and a phosphonate ester at the C5' position.

Career Highlights

Throughout his career, Philippe Mochirian has worked with various organizations, including LCB Pharma Inc. and the University of Ottawa. His expertise in the field has allowed him to contribute to significant advancements in medicinal chemistry.

Collaborations

Mochirian has collaborated with notable individuals in his field, including Yvan Guindon and Mona Nemer. These partnerships have further enhanced his research and development efforts.

Conclusion

Philippe Mochirian is a distinguished inventor whose work in nucleoside analogues has the potential to impact the fields of oncology and virology. His innovative compounds and collaborations reflect his commitment to advancing medicinal chemistry.